Aspira Women’s Health (AWH)
搜索文档
Aspira Women’s Health (AWH) - 2021 Q1 - Earnings Call Transcript
2021-05-14 11:37
Aspira Women's Health Inc. (NASDAQ:AWH) Q1 2021 Results Conference Call May 13, 2021 4:30 PM ET Company Participants Valerie Palmieri - President and CEO Bob Beechey - CFO Kaile Zagger - COO Dr. Lesley Northrop - Chief Scientific Officer Dr. Elena Ratner - Global Chief Medical Advisor and Clinical and Translational Medicine Conference Call Participants Andrew Brackmann - William Blair Kyle Mikson - Cantor Fitzgerald Sandy Draper - Truist Securities Operator Good afternoon, ladies and gentlemen, and welcome ...
Aspira Women’s Health (AWH) - 2020 Q4 - Earnings Call Transcript
2021-03-26 11:08
Aspira Women's Health Inc. (NASDAQ:AWH) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Valerie Palmieri - President and CEO Robert Beechey - CFO Kaile Zagger - COO Lesley Northrop - Chief Scientific Officer Elena Ratner - Global Chief Medical Advisor and Clinical and Translational Medicine Conference Call Participants Andrew Brackmann - William Blair Kyle Mikson - Cantor Fitzgerald Operator Good afternoon, ladies and gentlemen, and welcome to Aspira Women's Health Fourth Qua ...
Aspira Women’s Health (AWH) - 2020 Q3 - Earnings Call Transcript
2020-11-13 11:36
Aspira Women's Health Inc. (NASDAQ:AWH) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Valerie Palmieri - CEO, President & Director Robert Beechey - CFO Conference Call Participants Operator Hello ladies and gentlemen. Good afternoon, and welcome to Aspira Women's Health Third Quarter 2020 Conference Call. My name is Jane, and I will be your coordinator for the call today. [Operator Instructions] As a reminder, this conference is being recorded today. Leading the call tod ...
Aspira Women’s Health (AWH) - 2020 Q3 - Quarterly Report
2020-11-13 06:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-34810 Aspira Women's Health Inc. (Exact name of registrant as specified in its charter) Delaware 33-0595156 ( ...
Aspira Women’s Health (AWH) - 2020 Q2 - Earnings Call Transcript
2020-08-14 10:58
Aspira Women's Health, Inc. (NASDAQ:AWH) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Valerie Palmieri - CEO, President & Director Lesley Northrop - Global Medical Director, Genetic Services Robert Beechey - CFO Conference Call Participants Andrew Brackmann - William Blair & Company Operator Good afternoon, and welcome to Aspira Women's Health Second Quarter 2020 Conference Call. My name is Jessie, and I will be your coordinator for the call today. [Operator Instructions] ...
Aspira Women’s Health (AWH) - 2020 Q2 - Quarterly Report
2020-08-14 06:23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-34810 Aspira Women's Health Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |----- ...
Aspira Women’s Health (AWH) - 2020 Q1 - Earnings Call Transcript
2020-05-15 08:29
Vermillion, Inc. (VRML) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Valerie Palmieri – President and Chief Executive Officer Chris Goulart – Senior Vice President of Commercial Operations Bob Beechey – Chief Financial Officer Conference Call Participants Brian Weinstein – William Blair Jeb Terry – Aberdeen Investment Management Kyle Mikson – Cantor Fitzgerald Operator Good afternoon, ladies and gentlemen, and welcome to Vermillion's First Quarter 2020 Conference Call. My na ...
Aspira Women’s Health (AWH) - 2020 Q1 - Quarterly Report
2020-05-15 05:17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-34810 Vermillion, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0595156 (State or other ...